Form 8-K - Current report:
SEC Accession No. 0001437749-25-013977
Filing Date
2025-05-01
Accepted
2025-05-01 08:33:12
Documents
20
Period of Report
2025-04-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20250422_8k.htm   iXBRL 8-K 55265
2 EXHIBIT 3.1 ex_810109.htm EX-3.1 353536
3 EXHIBIT 10.1 ex_810062.htm EX-10.1 16793
4 EXHIBIT 10.2 ex_810063.htm EX-10.2 176990
5 EXHIBIT 10.3 ex_810064.htm EX-10.3 13544
6 EXHIBIT 10.4 ex_810065.htm EX-10.4 17602
7 EXHIBIT 99.1 ex_805363.htm EX-99.1 12493
  Complete submission text file 0001437749-25-013977.txt   931651

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA wint-20250430.xsd EX-101.SCH 3578
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20250430_def.xml EX-101.DEF 11803
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20250430_lab.xml EX-101.LAB 15847
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20250430_pre.xml EX-101.PRE 12018
22 EXTRACTED XBRL INSTANCE DOCUMENT wint20250422_8k_htm.xml XML 2956
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 25899667
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)